MedPath

Risk Scoring Model for Endometrial Cancer

Conditions
Oncology
Interventions
Other: Scoring model
Registration Number
NCT03298100
Lead Sponsor
Ain Shams University
Brief Summary

A prospective cohort study to assess RHEA ( recurrent vaginal bleeding, hypertension, endometrial thickness and age) scoring model for prediction of endometrial carcinoma

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • All postmenopausalwomen with vaginal bleeding and endometrial thickness more than 4 mm
Exclusion Criteria
  • all patients with vaginal bleeding arising from cervical or vaginal or vulval disease or due to hormonal replacement therapy (scheduled bleeding).

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Postmenopausal womenScoring model-
Primary Outcome Measures
NameTimeMethod
Specificity and sensitivity of RHEA scoring mdelOne year

Positive and negative productive values, specificity and sensitivity of RHEA scoring model

Secondary Outcome Measures
NameTimeMethod
Variables to increase specificity and sensitivity of the score modelOne year

Obesity, diabetes mellitus and family history

Trial Locations

Locations (1)

Ain Shams University Maternity Hospital

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath